Galectin Therapeutics
GALT
#8074
Rank
NZ$0.27 B
Marketcap
$4.45
Share price
1.48%
Change (1 day)
38.79%
Change (1 year)

Galectin Therapeutics (GALT) - Cash on Hand

Cash on Hand as of June 2024 : NZ$41.37 M

According to Galectin Therapeutics's latest financial reports the company has NZ$41.37 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galectin Therapeutics - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$29.28 M-49.42%
2021-12-31NZ$57.89 M53.4%
2020-12-31NZ$37.73 M-46.38%
2019-12-31NZ$70.38 M472.33%
2018-12-31NZ$12.29 M186.08%
2017-12-31NZ$4.29 M-80.62%
2016-12-31NZ$22.17 M-41.34%
2015-12-31NZ$37.8 M1.82%
2014-12-31NZ$37.13 M190.73%
2013-12-31NZ$12.77 M11.82%
2012-12-31NZ$11.42 M39.35%
2011-12-31NZ$8.19 M6.91%
2010-12-31NZ$7.66 M2102.24%
2009-12-31NZ$0.34 M-36.84%
2008-12-31NZ$0.55 M-67.71%
2007-12-31NZ$1.7 M-79.17%
2006-12-31NZ$8.19 M25.41%
2005-12-31NZ$6.53 M-56.44%
2004-12-31NZ$15 M28.17%
2003-12-31NZ$11.7 M218.81%
2002-12-31NZ$3.67 M2.23%
2001-12-31NZ$3.59 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$1.57 B 3,714.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.40 B 867.89%๐Ÿ‡บ๐Ÿ‡ธ USA